Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-1.776; its P/E ratio is -6.96; Cabaletta Bio is scheduled to report earnings on March 15, 2023, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -11.78M	$ -13.06M	$ -13.00M	$ -13.89M	$ -11.56M
EBITDA	$ -11.41M	$ -12.82M	$ -12.78M	$ -13.66M	$ -11.34M
Net Income Common Stockholders	$ -11.43M	$ -11.31M	$ -12.95M	$ -13.89M	$ -11.56M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 85.89M	$ 96.81M	$ 109.21M	$ 122.22M	$ 119.26M
Total Assets	$ 91.67M	$ 102.02M	$ 113.66M	$ 126.34M	$ 122.64M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -85.89M	$ -96.81M	$ -109.21M	$ -122.22M	$ -119.26M
Total Liabilities	$ 5.80M	$ 6.49M	$ 6.93M	$ 8.38M	$ 6.02M
Stockholders Equity	$ 85.87M	$ 95.53M	$ 106.72M	$ 117.96M	$ 116.61M
Cash Flow	-
Free Cash Flow	$ -11.01M	$ -12.42M	$ -12.96M	$ -10.67M	$ -8.87M
Operating Cash Flow	$ -9.91M	$ -11.53M	$ -12.81M	$ -10.52M	$ -8.34M
Investing Cash Flow	$ 23.91M	$ -898.00K	$ -49.91M	$ 849.00K	$ 1.77M
Financing Cash Flow	$ 0.00	$ 40.00K	$ 51.00K	$ 13.63M	$ 25.34M

Currency in USD

Cabaletta Bio Earnings and Revenue History

Income Statement >

Cabaletta Bio Debt to Assets

Balance Sheet >

Cabaletta Bio Cash Flow

Cash Flow >

Cabaletta Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing